Articles tagged with Covid 19 Vaccines
A recent study published in Nature Cardiovascular Research found a link between COVID-19 and postural orthostatic tachycardia syndrome (POTS), with patients infected five times more likely to develop the condition. Vaccination was also linked, but at a lower risk, emphasizing the importance of vaccination in reducing POTS.
A new study published in BMJ Open found that COVID vaccines are more effective in areas with higher infection rates, highlighting the need for targeted vaccine distribution. The researchers calculated absolute risk reduction and number needed to be vaccinated, revealing significant differences in effectiveness across geographical regions.
A survey study found adolescents who received routine childhood vaccines were more likely to receive a COVID-19 vaccine dose. This may indicate that addressing hesitancy about routine vaccinations can reduce concerns about COVID-19 vaccines.
A new study in The American Journal of Medicine found that adults who neglect COVID-19 vaccination may also neglect basic road safety guidelines. Unvaccinated individuals were more likely to be involved in traffic crashes, with a 72% increased relative risk compared to those vaccinated.
A randomized controlled trial found that a low-carbohydrate, high-fat diet helped patients with type 2 diabetes achieve better weight loss and glucose control over a 6-month intervention compared to a high-carb, low-fat diet. However, changes were not sustained 3 months after the intervention.
Researchers found that Covid vaccines effectively protect HIV-positive individuals, particularly after a third booster shot. The study also revealed a surprisingly strong cellular immune response in HIV-positive people, similar to those in healthy individuals.
A global study published in Nature finds that the unvaccinated face significant prejudice in most countries, with many vaccinated people harboring discriminatory attitudes towards them. The study suggests that this prejudice could lead to severe consequences for society, including hindered vaccination uptake and increased mistrust.
A national study confirms that vaccination significantly reduces disease severity and hospitalization risk for COVID-19, even among individuals who develop breakthrough cases. Hospital stays are shorter, ICU admissions are less common, and hospital deaths are lower among vaccinated adults compared to unvaccinated individuals.
A recent study published in Frontiers in Medicine found that COVID-19 vaccines significantly reduce the likelihood of reinfection and severe symptoms. Vaccinated individuals who have recovered from the virus have a 50% to 60% lower risk of reinfection compared to those who are not vaccinated.
Administration of vaccine boosters to nursing home residents significantly reduces SARS-CoV-2 infections and hospitalizations. The study suggests that booster vaccination may play a crucial role in preventing COVID-19-related morbidity and mortality among vulnerable populations.
The Cochrane review analyzed data from 41 randomized controlled trials of 12 different COVID-19 vaccines, involving 433,838 people worldwide. The review found that most vaccines reduced the risk of COVID-19 infection and severe disease, with few reported side effects.
Research finds that individuals who received monoclonal antibodies before COVID vaccination exhibit a diverse antibody response, increasing the coverage provided by vaccines. This phenomenon, known as antibody feedback inhibition, is beneficial for diversifying immune responses to viruses.
A new study from Ohio State University found that individuals with greater certainty in their views on vaccines are more likely to become vaccine advocates. This discovery could aid in identifying target audiences for interventions aimed at increasing pro-vaccine certainty.
A systematic review of 23 studies found COVID-19 mRNA vaccine-associated myopericarditis is rare in adolescents and young adults with a low incidence rate. The condition generally has favorable early outcomes, but continued follow-up is recommended.
A new study found that earlier vaccine hesitancy predicts subsequent nocebo side-effects following the booster vaccination. Only 16% of one’s vaccine side effects were explained by earlier vaccine hesitancy, highlighting the importance of tailored public health messaging.
A large study found that most Canadian children and adults younger than 60 had been exposed to SARS-CoV-2 through a combination of vaccination and infection. The study, conducted in British Columbia, shows a dramatic change in the proportion of the population with antibodies over the first 2.5 years of the pandemic.
Research found that while broad T-cell response against SARS-CoV-2 spike protein is currently protective, recognition of seven out of ten T-cell targets mutated in COVID-19 variants is impaired. The study suggests ongoing mutation could lead to decreased overall immune system protection.
A follow-up study found that the 2-dose vaccines still provided protection against lung disease one year after vaccination as infants. The adjuvanted protein vaccine candidate maintained higher levels of neutralizing antibodies and provided superior protection compared to the mRNA vaccine.
A study published in PLOS Medicine suggests that primary vaccination provides moderate protection against Omicron infection regardless of prior infection history. However, the additional benefit of an original booster dose is unclear in people who have previously experienced COVID-19 infection.
Researchers have found that experimental vaccines, including a protein-based vaccine candidate with an adjuvant, provide superior protection against lung disease and higher levels of neutralizing antibodies compared to mRNA vaccines. The results inform the optimization and development of COVID-19 vaccines for young infant populations.
A global Phase 2/3 clinical trial found that vaccination with SCB-2019 reduced the risk of transmitting SARS-CoV-2 infection to household members. The study showed a significant reduction in symptomatic cases among vaccinated household contacts and indicated that vaccines can play an important role in controlling future outbreaks.
A large study from Argentina found that COVID-19 vaccines remain effective in preventing death in children and adolescents, regardless of the predominant circulating variant. The study's results show that vaccinated children had a 67% reduced risk of death related to COVID-19 infection during the omicron period.
Healthcare workers in Massachusetts prefer strategies supporting education, trust in community-based communication, and accessibility of vaccination sites to increase COVID-19 vaccine and booster rates. These approaches were seen as more effective than mandates or incentives in improving vaccination uptake.
A Brazilian team developed an electrochemical immunosensor to detect SARS-CoV-2 antibodies, achieving 88.7% sensitivity and 100% specificity in just five minutes. The device can be adapted for other diseases and has potential for monitoring seroconversion and seroprevalence.
Researchers found that antibodies against one of the two main domains of the SARS-CoV-2 viral entry machinery elicit a broad antibody response against many variants. This suggests strategies for clinical development of variant-resistant vaccines.
Researchers at Texas A&M University engineered DARPins to block the interaction between the COVID-19 virus and host cells, significantly reducing disease progression. The nasal sprays showed effectiveness against various variants, including omicron, and could provide a lower-cost therapeutic option for those at high risk.
A recent study found that the proportion of COVID-19 deaths among young people increased in 2021 compared to 2020, resulting in a 7.4% rise in Years of Life Lost due to the virus. The median age of COVID-19 deaths decreased from 78 years in 2020 to 69 years in 2021.
A community pharmacy-led vaccination scheme in South East London successfully supported over 6,000 patients to overcome initial hesitancy around Covid-19 jabs. The programme, which ran for six months, found that a lack of understanding about the vaccine was the biggest reason for patients' hesitation.
A Rutgers study found that COVID-19 patients, especially those treated with antibiotics, experience significant disruptions in their gut microbiome balance. This imbalance may lead to the development of targeted probiotic supplements to improve treatment outcomes.
A team from UNIGE has revealed the existence of a hidden 'pocket' on the surface of the non-structural protein Nsp1, which could be used to develop new treatments against Covid-19. This discovery paves the way for innovative therapies targeting the Nsp1 protein and its potential application against other coronaviruses.
A systematic review of 36 studies found that influenza vaccination reduced the risk of SARS-CoV-2 infection by 20% and poor outcomes like ICU admission and death by 17-31%. The findings suggest that routine influenza vaccination could offer non-specific immunity against COVID-19 symptoms.
Researchers from UCSF and the San Francisco VA Health Care System found that veterans with PTSD had an 8% increased risk of death and a 9% increased risk of hospitalization compared to those without psychiatric diagnoses. Patients with psychosis had a 58% increased risk of death and a 66% increased risk of hospitalization.
Three circulating omicron subvariants have shown improved resistance to vaccine- and infection-generated neutralizing antibodies. BQ.1 and BQ.1.1 are dominating US infections, while BA.2.75.2 is the best at evading neutralizing antibodies.
A new study published in PLOS Medicine found that COVID-19 vaccination provides significant protection against reinfection, with varying levels of effectiveness (60-94%) across different variants. The study analyzed data from over 200,000 people in Denmark and showed that vaccination offered up to 71% protection during the Alpha period...
A large study found that mRNA vaccines increased myocarditis risk in younger males, especially after the second dose. Absolute rates were low, with higher observed rates compared to expected rates.
The study found that COVID-19 vaccination in New York City reduced severe outcomes and avoided substantial economic losses. Every dollar invested yielded estimated savings of $10.19 in health costs.
A study found that NFL fan attendance was associated with increased COVID-19 incidence in the host county and surrounding areas. The findings suggest that large events require extra precautions when vaccines, testing, and countermeasures are not readily available.
Outreach messages via electronic health record patient portals increased well child care visit scheduling and COVID-19 vaccine receipt in a randomized clinical trial of 945 patients. This tool may help restore delayed well child care in populations affected by the pandemic.
Parental COVID-19 vaccination was associated with lower risk of hospitalization in children under 5, supporting widespread vaccination recommendations for young children. The study's results reinforce the importance of parental immunization during high-risk periods.
The FDA's investigation into its own oversight of clinical trials reveals a concerning lack of surveillance, leaving room for scientific misconduct. Experts argue that the agency should inspect sites more frequently to ensure data quality and integrity.
Researchers have developed a new nasal vaccine that induces potent lung immunity and protects against SARS-CoV-2 infection in mice. The vaccine approach, which targets the nose, airways, and lungs, has shown promising results in preventing COVID-19 infection.
A nationwide survey in Germany found that 82% of medical and nursing personnel were vaccinated at least once, with 75% having received two doses. In contrast to the general population, unvaccinated healthcare workers had stronger concerns about vaccine safety and effectiveness. The study suggests a need for targeted measures to convinc...
A new study reveals that COVID-19 causes a significant disruption in vaginal microbiota balance, leading to an increased risk of preterm birth. The research found a 70% change in microbiota and higher levels of pathogenic bacteria in infected women compared to control groups.
A study analyzing seroprevalence data found that global COVID-19 infection rates are likely higher than reported, with 59.2% of the population seropositive as of September 2021. The study suggests that two-thirds of the global population may have antibodies from vaccination or infection.
Researchers mapped out variations in vaccine distribution policies among 29 countries, highlighting differing priorities such as age, comorbidities, and occupation. The study suggests that vaccination schedules differ from resource allocation strategies in healthcare, reflecting diverse moral judgments underlying each approach.
A study by Children's Hospital of Philadelphia researchers found that COVID-19 vaccination results in higher antibody concentrations compared to natural infection, providing robust protection for mothers during pregnancy. The study also suggests optimal vaccine timing can maximize the transfer of antibodies to babies.
A new study found that racial resentment significantly motivates Americans to express confidence in misinformed beliefs about policy issues associated with race, such as human-caused climate change and COVID-19 origins. In contrast, this effect was not observed for less racially charged topics like childhood vaccine safety.
A study found that media literacy and trust in health experts are more powerful predictors of COVID-19 vaccine intentions than previous behavior or knowledge. Researchers also discovered that people who refused flu vaccines had lower future vaccine intentions despite higher COVID-19 knowledge.
A pre-pandemic conspiratorial mindset was associated with hesitance to accept COVID-19 vaccines, a new study suggests. Individuals who held conspiracy theories prior to the pandemic were more likely to believe in COVID-19 conspiracy theories and report hesitancy to be vaccinated.
A recent study by the Universities of Bonn and Shanxi found that Covid-19 vaccination stimulates immune response, enabling anti-PD-1 therapy to work better against nasopharyngeal cancer. Vaccinated patients responded significantly better to cancer therapy than unvaccinated counterparts.
A new study confirms that COVID-19 deaths among children and young people are rare, with most fatalities occurring in those with severe neurodisability or compromised immune systems. The analysis of detailed data showed that half of COVID-19 deaths occurred within 30 days of infection.
A study found that males younger than 40 years old who received the Moderna COVID-19 vaccine had the highest rates of myocarditis, but overall cases are rare. The study suggests that choosing specific vaccines for certain populations may maximize benefits and minimize adverse events.
A new study from Rice University found that Latino communities are hesitant to get vaccinated against COVID-19 due to concerns over side effects and mistrust of health officials. The study, which focused on communities near the U.S.-Mexico border, found that 44% of community health workers reported patients believing vaccines can have ...
Researchers found significant decline in vaccine confidence among adults since pre-pandemic surveys, regardless of age, gender, education, and ethnicity. Post-pandemic participants reported a fall in confidence in vaccines, with nearly one in four experiencing a decrease.
The study, led by C. Buddy Creech, MD, MPH, shows the vaccine is safe and generates robust immune responses in young children, providing protection against COVID-19-related hospitalization and death. The findings echo previous results, which found the vaccine to be effective in older children.
A comparative epidemiological analysis found a significant decrease in SARS-CoV-2 outbreaks and cases in German care homes following the introduction of COVID-19 vaccination. The median number of cases/outbreaks fell from 21 to 8, while the case-fatality rate decreased from 15.7% to 10.0%.
A population-level study found that COVID-19 vaccine doses 2-3 were associated with a higher relative risk but small absolute increase in glomerular disease relapse. Most flares were mild, and the benefits of vaccination outweighed the risks.
Researchers identified specific monkeypox mutations that contribute to its continued infectiousness. The virus is accumulating mutations where drugs and antibodies from vaccines are supposed to bind, making it smarter and more infectious.
A comprehensive review and meta-analysis found that young adults under 40 have a slightly elevated risk for myocarditis or pericarditis after mRNA COVID-19 vaccination. The analysis analyzed data from over 58 million participants and explored the relationship between COVID-19 vaccine and these rare but dangerous adverse reactions.
A new study led by Duke-NUS Medical School scientists found that inactivated SARS-CoV-2 vaccines elicit a broad immune response against different proteins on the virus, while mRNA vaccines stimulate a single spike protein response. This broader T-cell response may be beneficial in preventing severe COVID-19 disease.